Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
207.88
-13.27 (-6.00%)
At close: Aug 28, 2026, 4:00 PM EDT
208.55
+0.67 (0.32%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Revolution Medicines Employees
Revolution Medicines had 883 employees as of December 31, 2025. The number of employees increased by 349 or 65.36% compared to the previous year.
Employees
883
Change (1Y)
349
Growth (1Y)
65.36%
Revenue / Employee
n/a
Profits / Employee
-$2,002,588
Market Cap
44.56B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 883 | 349 | 65.36% |
| Dec 31, 2024 | 534 | 156 | 41.27% |
| Dec 31, 2023 | 378 | 132 | 53.66% |
| Dec 31, 2022 | 246 | 58 | 30.85% |
| Dec 31, 2021 | 188 | 63 | 50.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,119 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
RVMD News
- 1 day ago - Revolution Medicines price target raised to $265 from $220 at UBS - TheFly
- 1 day ago - Revolution Medicines price target raised to $275 from $240 at Guggenheim - TheFly
- 1 day ago - Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent - WSJ
- 2 days ago - Revolution Medicines Stock (RVMD) Gets Price Target Hike on New Revenue-Generating Cancer Drug - TipRanks
- 2 days ago - Revolution Medicines price target raised to $246 from $227 at JPMorgan - TheFly
- 2 days ago - Revolution Medicines price target raised to $251 from $203 at RBC Capital - TheFly
- 2 days ago - Revolution Medicines price target raised to $248 from $230 at Raymond James - TheFly
- 2 days ago - Revolution Medicines price target raised to $260 from $230 at Oppenheimer - TheFly